Why the study?
What are the plasma concentrations of propranolol and 4-hydroxypropranolol during chronic oral therapy in hypertensive patients?
What are the plasma concentrations of propranolol and 4-hydroxypropranolol during chronic oral therapy in hypertensive patients?
Plasma levels of propranolol and its metabolite vary widely among individuals and correlate poorly with the administered daily dose.
Wide interindividual variability in propranolol levels should not yet change practice; leaves open whether monitoring improves outcomes in hypertension.
1 The plasma levels of propranolol and 4-hydroxypropranolol have been measured in 17 hypertensive patients receiving chronic oral therapy with propranolol. 2 The range of plasma propranolol concentrations was from 5.3 to 300 ng/ml, and that of 4-hydroxypropranolol was from 2.1 to 36.0 ng/ml. 3 The mean (+/- s.d.) plasma concentration ratio of 4-hydroxypropranolol to propranolol was 0.130 (+/- 0.005); however, a very wide range was observed with individual values ranging from 0.057 to 0.241. 4 A statistically significant correlation was observed between the plasma concentration of 4-hydroxypropranolol and that of propranolol. 5 Propranolol and 4-hydroxypropranolol plasma concentrations were each significantly, but poorly, correlated with daily propranolol dose. 6 The clinical significance of the results has been discussed.
No takes yet. Share an insight, caveat, or question.
Wong et al. (1979) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: